UPDATE : Thursday, December 13, 2018
상단여백
Hanmi’s US partner will test more to confirm NSCLC treatment’s efficacy
Hanmi Pharmaceutical said Thursday that Spectrum, Hanmi’s U.S. partner, wil...
by Lee Han-soo  |  2018-09-13 14:37
라인
Female workforce scarce in top 15 local pharmaceuticals
Among the top 15 domestic drug companies, Kwangdong Pharmaceutical has the ...
by Nam Doo-hyun  |  2018-09-13 11:41
라인
GC MS breaks ground for new local plant
GC MS, previously known as Green Cross MS, announced Wednesday that constru...
by Lee Han-soo  |  2018-09-12 14:58
라인
‘Xgeva reduces risk of bone problems in solid tumor patients’
Amgen Korea’s Xgeva (ingredient: denosumab), a therapy for bone metastases ...
by Nam Doo-hyun  |  2018-09-12 12:23
라인
ABL Bio, Yuhan sign cooperative agreement
ABL Bio said Monday that it has signed a license-out and cooperative agreem...
by Lee Han-soo  |  2018-09-11 16:54
라인
Shire’s SBS treatment to bring new hope to pediatric patients
Gattex (ingredient name: Teduglutide), Shire’s short bowel syndrome (SBS) t...
by Lee Han-soo  |  2018-09-11 16:17
라인
Hepatitis C patients wait for Maviret’s arrival
Korean physicians and patients have expressed high expectations for AbbVie ...
by Nam Doo-hyun  |  2018-09-11 16:16
라인
Medpecto to test immunotherapy combo with MSD
Medpacto, a subsidiary of Theragen ETEX, said Tuesday that the Ministry of ...
by Lee Han-soo  |  2018-09-11 13:04
라인
Astellas wins nod for phase-3 trial on gastric cancer treatment
Astellas has obtained the regulatory approval to go ahead with a global pha...
by Lee Hye-seon  |  2018-09-11 10:38
라인
MERS infection affects stock market
Pharmaceuticals and biotech businesses are gathering renewed attention afte...
by So Jae-hyeon  |  2018-09-10 16:25
라인
Kwangdong licenses Canadian company’s nonsteroidal anti-inflammatory drug candidate
Kwangdong Pharmaceutical said Monday that it has signed a licensing agreeme...
by Lee Han-soo  |  2018-09-10 14:23
라인
Pfizer Korea ordered to suspend imports of 3 drugs for poor quality control
The government has ordered Pfizer Korea to halt imports of three drugs for ...
by Lee Hye-seon  |  2018-09-07 16:24
라인
Biopharmaceuticals lead Korea’s drug output growth
Korea’s pharmaceutical output has exceeded 20 trillion won ($17.8 billion) ...
by Lee Hye-seon  |  2018-09-07 13:47
라인
Antihypertensive drug Kanarb tops output among local new drugs
Boryung Pharmaceutical’s antihypertensive treatment Kanarb marked the large...
by Lee Hye-seon  |  2018-09-07 11:08
라인
Opdivo-Yervoy okayed as first-line treatment for renal cell carcinoma
The Korean government has approved Ono Pharma Korea and Bristol-Myers Squib...
by Nam Doo-hyun  |  2018-09-06 15:02
라인
Spectrum announces new clinical trial results for Hanmi's lung cancer drug
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Tuesday that it present...
by Lee Han-soo  |  2018-09-06 14:34
라인
Antidiabetic combo Steglujan approved in Korea
MSD Korea said it has won approval to sell an antidiabetic combination drug...
by Lee Hye-seon  |  2018-09-06 11:55
라인
Hugel to set up US offshoot
Hugel said Wednesday that it plans to establish a subsidiary in the United ...
by Lee Han-soo  |  2018-09-06 11:55
라인
Seoul decides to reimburse Janssen’s plaque psoriasis treatment
Janssen, a subsidiary of Johnson and Johnson, said Wednesday the Ministry o...
by Lee Han-soo  |  2018-09-05 17:59
라인
Hanmi unveils research results for Rosuzet and Amosartan Plus
Hanmi Pharmaceutical has presented research results on Rosuzet and Amosarta...
by Lee Han-soo  |  2018-09-05 16:14
여백
여백
여백
Back to Top